1120 15th Street HH 1013 Augusta, GA 30912 Office: (706) 721-2535 E-mail: dferris@georgiahealth.edu

Ferris, Daron, M.D.

Dr. Daron Ferris

Ferris, Daron, M.D.
Director, HPV Epidemiology & Prevention Program

Member, Gynecologic Oncology Multi-Disciplinary Team
Member, Clinical Oncology Program
Professor of Obstetrics & Gynecology, Section of Gynecological Oncology
GRU Cancer Center

 

 

1120 15th Street, BAA 7411
Telephone:  706-721-3992
Fax:  706-721-9777
dferris@gru.edu

IFL Link | PubMed Link

 

Professional Overview

Teaching Areas
Colposcopy, high resolution anoscopy, Infrared Coagulation surgery, abnormal cervical and anal Pap tests, lower genital tract neoplasias, human papillomavirus, recurrent and complicated vaginitis, vulvar disorders, , women’s health, global health.

Research Areas
Lower genital tract neoplasias, human papillomavirus, colposcopy, recurrent and complicated vaginitis, vaccines, women’s health.

Clinical Interests
Colposcopy, high resolution anoscopy, Infrared Coagulation surgery, abnormal cervical and anal Pap tests, lower genital tract neoplasias, human papillomavirus, recurrent and complicated vaginitis, vulvar disorders, , women’s health, global health.

 

Current Funding

Funding Source Title Start Date End Date
Cepheid Specimen Collection for Performance Evaluation of the Xpert® HPV Assay in a Colposcopy Referral Population 20-Sep-12 31-Dec-13
Eisai Medical Research, Inc. A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of ZYC101a in the Treatment of High-Grade Cervical Intraepithelial Lesions (CIN 2/3) of the Uterine Cervix 1-Sep-05 31-Aug-20
Georgia Research Alliance Tush Brush 1-Oct-12 30-Jun-13
GlaxoSmithKline A Phase III, Double-Blind, Randomized, Controlled Study to Evaluate the Safety, Immunogenicity and Efficacy of GlaxoSmithKline Biologicasl’ HPV-16/18 L1/AS04 Vaccine Administered Intramuscularly According to a Three-Dose Schedule (0, 1, 6 month) in Healthy Adult Female Subjects Aged 26 Years and Above. 1-May-06 30-Jul-14
Hoffmann-La Roche, Inc. A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Study of the Safety and Response Rate of 3 Subcutaneously Administered Doses of 5 x 107 pfu RO5217790 in Patients with High Grade Cervical Intraepithelial Neoplasia Grade 2 or 3 Associated with High Risk HPV Infection 3-Mar-10 28-May-13
Medicis Global Services Corporation A Phase 3, Multicenter, Randomized, Double-blind, Vehicle controlled Study to Evaluate the Safety and Efficacy of Product 55394 in the Treatment of Bacterial Vaginosis Medicis Protocol Number: MP-1601-01 23-Aug-12 1-Jun-13
Merck & Company A Safety and Immunogenicity Study of Quadrivalent HPV (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in Preadolescents and Adolescents 7-Jan-04 6-Jun-15
Merck & Company A Study to Evaluate the Efficacy of Quadrivalent HPV (Types 6, 11, 16, and 18) L1 Virus-Like Particle (VLP) in Reducing the Incidence of HPV 6-, 11-, 16-, and 18-Related Anogenital Warts, and the Incidence of HPV 6-, 11-, 16- and 18-Related Genital Infection in 16- to 23-Year-Old Men 20-Oct-04 31-Oct-14
Merck & Company A Phase III Clinical Trial to Study the Immunogenicity, Tolerability, and Manufacturing Consistency of V503 (A Mulitvalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (9 to 15 year olds) with a Comparision to Young Women (16 to 26 year olds) 15-Aug-09 31-Aug-13
Merck Sharp & Dohme Corp./Merck A Randomized, International, Double-Blinded (With In-House Blinding), Controlled with GARDASIL, Dose-Ranging, Tolerability, Immunogenicity, and Efficacy Study of a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Administered to 16 to 26 Year Old Women 11-Oct-07 10-Oct-12
Methylgene, Inc. A Randomized, Double-Blind Placebo-Controlled Phase ll Study of Fluconazole Versus Fluconazole +MCGD290 for the Treatment of Moderate to Severe Acute Vulvovaginal Candidiasis 16-Mar-12 15-Mar-13
New York Academy of Medicine Dia Del Mercado – Cervical Cancer Screening in the Marketplace
(Fellow: Claire Vaughan)
1-Jun-12 31-May-13
National Cancer Institute/ NIH/ DHHS Clinical Evaluation of Polarized Light Assisted Colposcopy 18-Mar-11 28-Feb-14